CSF1R-IN-27
CSF1R-IN-27 is a CSF1R inhibitor with oral effectiveness, kinome-wide selective profile, low cellular cytotoxicity, and CSF1R IC50 values of 19 nM, 88 nM, 173 nM, 797 nM, 1448 nM, and >3000 nM. CSF1R-IN-27 suppresses M-CSF-induced phosphorylation of CSF1R, AKT, and ERK in macrophages, and inhibits hepatic p-CSF1R/p-AKT/p-ERK signaling. CSF1R-IN-27 reduces serum transaminase levels, improves hepatic histopathology, alleviates inflammatory cell infiltration, and decreases circulating TNF-α and IL-6 levels. CSF1R-IN-27 can be used for the research of acute liver injury.
For research use only. We do not sell to patients.
- CAS No.: 3034296-91-5
- Formula: C27H30F3N7O3
- Molecular Weight:557.57
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
IL-6 |
TNF-α |
In Vitro
CSF1R-IN-27 (C52) potently inhibits the proliferation of BaF3-ETV6-CSF1R cells at 72 h, with an IC50 value of 0.298 μM[1].
CSF1R-IN-27 (72 h) exhibits low cytotoxicity in H9C2, HUVEC and HepG2 cells, and moderate cytotoxicity in HEK293 and LX-2 cells, with CC50 values ranging from 15.25 μM to >40 μM across all tested cell lines[1].
CSF1R-IN-27 (16-2000 nM; 4 h pretreatment, 30 min M-CSF stimulation) inhibits M-CSF-induced phosphorylation of CSF1R, AKT and ERK in a concentration-dependent manner in RAW264.7 cells and bone marrow-derived macrophages (BMDMs)[1].
CSF1R-IN-27 (24 h) exhibits lower cytotoxicity than PLX3397 in RAW264.7 cells, with a CC50 of 34.70 μM after 24 h of exposure[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:RAW264.7, bone marrow-derived macrophages (BMDMs)
-
Concentration:0, 16, 80, 400, 2000 nM
-
Incubation Time:4 h (pretreatment); 30 min (M-CSF stimulation)
-
Result:Induced concentration-dependent suppression of M-CSF-induced phosphorylation of CSF1R, AKT, and ERK in both RAW264.7 cells and BMDMs.
At concentrations ≥400 nM, substantially attenuated p-CSF1R, p-AKT, and p-ERK levels, with inhibitory effects approaching those of PLX3397 at 400 nM.
Parmacokinetics
| Species | Dose | Route | Cmax | Tmax | T1/2 | Vz | CL | AUC0-t | Bioavailability |
|---|---|---|---|---|---|---|---|---|---|
| Mice[1] | 10 mg/kg | p.o. | 1612 μg/L | 0.08 h | 3.99 h | 43.56 L/kg | 7.91 L/h/kg | 1312 h·μg/L | 37 % |
| Mice[1] | 10 mg/kg | i.v. | 7943 μg/L | 0.08 h | 4.55 h | 19.92 L/kg | 2.94 L/h/kg | 3499 h·μg/L | / |
| Mice[1] | 10 mg/kg | i.p. | 3613 μg/L | 0.21 h | 4.45 h | 17.45 L/kg | 2.91 L/h/kg | 3515 h·μg/L | / |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (male, 8 weeks old, 20-25 g, acetaminophen-induced acute liver injury)[1]
-
Dosage:10 mg/kg; 20 mg/kg
-
Administration:p.o.; single dose
-
Result:Dose-dependently reduced serum ALT and AST levels compared to the acetaminophen-only model group.
Reduced serum TNF-α and IL-6 levels, with the 20 mg/kg dose showing a more pronounced effect.
Dose-dependently reduced the necrotic area in liver tissue, with the 20 mg/kg dose yielding a greater reduction than the 10 mg/kg dose.
Dose-dependently suppressed hepatic infiltration of CD11b+ and F4/80+ inflammatory macrophages, and reduced the number of TUNEL-positive apoptotic hepatocytes.
Dose-dependently decreased hepatic levels of p-CSF1R, p-AKT, and p-ERK.
Chemical Information
-
CAS No. 3034296-91-5
-
Molecular Weight 557.57
-
Formula C27H30F3N7O3
-
SMILES
O=C(N1CCN(C2=CC=C(NC3=NC=CC(OC4=CC=C(NC(C(C)C)=O)C=C4)=N3)C=C2C(F)(F)F)CC1)NC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)